SUPPLEMENT SCIENCEInsights
Search

Search Insights

Try choline, nano-curcumin or probiotics.

    Ingredient guide · Ingredient reference

    Is melatonin good for COVID-19?

    Melatonin has been investigated as an adjunct in COVID-19, but the evidence does not establish it as a home treatment, preventive or replacement for indicated antivirals. Promising results in small hospital studies do not automatically apply to a person with a new mild infection.

    Read the evidence ↓

    Supplement Science Insights Editorial Team

    Published September 23, 2026

    A positive review studied a narrow setting

    A 2025 meta-analysis pooled three randomized studies involving 451 patients with severe-to-critical COVID-19 and reported lower in-hospital mortality with melatonin. These were treatment studies in seriously ill patients, not trials establishing protection against infection or effectiveness of retail gummies at home. [1]

    The authors described important limitations

    Only three trials contributed, two lacked placebo groups, doses varied and one study was small. The review called its findings provisional. Those constraints matter even when a pooled statistical result is positive; they do not supply a generally appropriate dose or prove benefit in a different population. [1]

    Do not miss the early-treatment window

    CDC outpatient guidance recommends prompt evaluation for people at higher risk of severe disease. Depending on the treatment, indicated antivirals generally need to start within five to seven days of symptom onset. A supplement experiment should not delay that assessment. [2]

    Use the actual clinical situation

    Imagine an older adult with a positive test reads about melatonin in intensive care. The useful next step is timely treatment assessment and interaction review, not copying a hospital research dose. Sleep difficulties can be discussed separately from antiviral treatment. [2][3]

    Hypothetical example — match evidence to setting
    SettingWhat can be inferred
    Hospital adjunct trialsLimited treatment signal
    New mild infectionDifferent clinical question
    Prevention claimNot established by treatment trials
    High-risk outpatientPrompt treatment assessment
    Is melatonin good for COVID-19? — original article outline diagram
    Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

    Sources for this article

    1. Benefits of melatonin on mortality in severe-to-critical COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials - PMC
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
    2. COVID-19 Treatment Clinical Care for Outpatients | Covid | CDC
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
    3. Melatonin: What You Need To Know | NCCIH
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.